- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05906433
Anestésico ideal para injeções de corticosteróides para osteoartrite do joelho (Injections)
Anestésico ideal para injeções de corticosteróides para osteoartrite do joelho.
To evaluate pain relief from corticosteroid injection with and without anesthetic as well as with variable volume of anesthetic. Pain relief will be measured using the VAS pain score at the time of the injection as well as several time points following the injection to capture pain relief longevity. The investigators intend to evaluate how well the patients tolerate corticosteroid mixtures without anesthetic as well as with different volumes of anesthetic. Primary measure will be the time from procedure when postoperative status is considered success (as measured by global perceived improvement score).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Primary objective is to evaluate pain relief from corticosteroids, Kenalog without anesthetic as well as with different volumes of anesthetic. The investigators will measure the VAS pain score at the time of the injection as well as several time points following the injection. Additionally, the investigators will evaluate how long the injection provided pain relief for the patient.
The secondary intend is to evaluate how well the patients tolerate Kenalog mixtures without anesthetic as well as with different volumes of anesthetic by using the VAS pain scale.
The investigators hypothesize that patient with lower volume of injection will experience less pain during the procedure and that there will be no statistically significant difference in pain level between the study groups during the study period.
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 1
Contactos e Locais
Locais de estudo
-
-
Florida
-
Tampa, Florida, Estados Unidos, 33637
- Florida Orthopaedic Institute
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients must be 18 years of age and be able to consent for themselves.
- OA grade Kellgren Lawrence Stage II or III.
- Diagnosis of primary osteoarthritis.
Exclusion Criteria:
- Patients with other forms of arthritis such as inflammatory arthritis.
- History of narcotic use for the past 6 months.
- Kellgren Lawrence arthritis grade 1 or 4.
- Pregnant women and prisoners.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Kenalog with 0ml bupivacaine
The intervention in this study is one intra-articular knee injection of synthetic corticosteroid (kenalog) and variable amount of anesthetic,0ml of bupivacaine. The patients will be randomized into this group. |
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
Outros nomes:
|
|
Experimental: Kenalog with 4ml bupivacaine
The intervention in this study is one intra-articular knee injection of synthetic corticosteroid (kenalog) and variable amount of anesthetic,4ml of bupivacaine. The patients will be randomized into this group. |
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
Outros nomes:
|
|
Experimental: Kenalog with 0.25% bupivacaine
The intervention in this study is one intra-articular knee injection of synthetic corticosteroid (kenalog) and variable amount of anesthetic,0.25% of bupivacaine. The patients will be randomized into this group. |
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Injection for Knee Pain
Prazo: Prior to procedure (in office)
|
Visual Analogue Scale (VAS) |
Prior to procedure (in office)
|
|
Injection for Knee Pain
Prazo: Immediate post procedure (in office)
|
Visual Analogue Scale (VAS) |
Immediate post procedure (in office)
|
|
Injection for Knee Pain
Prazo: 2 minutes post procedure (in office)
|
Visual Analogue Scale (VAS) |
2 minutes post procedure (in office)
|
|
Injection for Knee Pain
Prazo: Day 1 post procedure (phone interview)
|
Visual Analogue Scale (VAS) |
Day 1 post procedure (phone interview)
|
|
Injection for Knee Pain
Prazo: Day 14 post procedure (through EDC)
|
Visual Analogue Scale (VAS) |
Day 14 post procedure (through EDC)
|
|
Injection for Knee Pain
Prazo: Day 42 post procedure (in office)
|
Visual Analogue Scale (VAS) |
Day 42 post procedure (in office)
|
|
Injection for Knee Pain
Prazo: Day 84 post procedure (through EDC)
|
Visual Analogue Scale (VAS) |
Day 84 post procedure (through EDC)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Assessment of Knee Pain
Prazo: Immediate Post-op (in office)
|
Global Perceived Improvement |
Immediate Post-op (in office)
|
|
Assessment of Knee Pain
Prazo: Day 1 post procedure (phone interview)
|
Global Perceived Improvement |
Day 1 post procedure (phone interview)
|
|
Assessment of Knee Pain
Prazo: Day 42 post procedure (in office)
|
Global Perceived Improvement |
Day 42 post procedure (in office)
|
|
Assessment of Knee Pain
Prazo: Day 84 post procedure (through EDC)
|
Global Perceived Improvement |
Day 84 post procedure (through EDC)
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Medications
Prazo: Prior to procedure (in office)
|
Review of Medications |
Prior to procedure (in office)
|
|
Medications
Prazo: Day 1 post procedure (phone interview)
|
Review of Medications |
Day 1 post procedure (phone interview)
|
|
Medications
Prazo: Day 14 post procedure (through EDC)
|
Review of Medications |
Day 14 post procedure (through EDC)
|
|
Medications
Prazo: Day 42 post procedure (in office)
|
Review of Medications |
Day 42 post procedure (in office)
|
|
Medications
Prazo: Day 84 post procedure (through EDC)
|
Review of Medications |
Day 84 post procedure (through EDC)
|
|
Review of Adverse Events
Prazo: Immediate post procedure (in office)
|
Any issues with procedure |
Immediate post procedure (in office)
|
|
Review of Adverse Events
Prazo: Day 1 post procedure (phone interview)
|
Any issues with procedure |
Day 1 post procedure (phone interview)
|
|
Review of Adverse Events
Prazo: Day 42 post procedure (in office)
|
Any issues with procedure |
Day 42 post procedure (in office)
|
|
Review of Adverse Events
Prazo: Day 84 post procedure (through EDC)
|
Any issues with procedure |
Day 84 post procedure (through EDC)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicações e links úteis
Publicações Gerais
- Bedard NA, Dowdle SB, Anthony CA, DeMik DE, McHugh MA, Bozic KJ, Callaghan JJ. Response to Letter to the Editor on "The AAHKS Clinical Research Award: What Are the Costs of Knee Osteoarthritis in the Year Prior to Total Knee Arthroplasty?". J Arthroplasty. 2018 Jan;33(1):307. doi: 10.1016/j.arth.2017.10.002. Epub 2017 Oct 10. No abstract available.
- Blankstein M, Lentine B, Nelms NJ. Common Practices in Intra-Articular Corticosteroid Injection for the Treatment of Knee Osteoarthritis: A Survey of the American Association of Hip and Knee Surgeons Membership. J Arthroplasty. 2021 Mar;36(3):845-850. doi: 10.1016/j.arth.2020.09.022. Epub 2020 Oct 8.
- Grishko V, Xu M, Wilson G, Pearsall AW 4th. Apoptosis and mitochondrial dysfunction in human chondrocytes following exposure to lidocaine, bupivacaine, and ropivacaine. J Bone Joint Surg Am. 2010 Mar;92(3):609-18. doi: 10.2106/JBJS.H.01847.
- Smith MD, Wetherall M, Darby T, Esterman A, Slavotinek J, Roberts-Thomson P, Coleman M, Ahern MJ. A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee. Rheumatology (Oxford). 2003 Dec;42(12):1477-85. doi: 10.1093/rheumatology/keg398. Epub 2003 Jul 16.
- Parker RD, Streem K, Schmitz L, Martineau PA; Marguerite Group. Efficacy of continuous intra-articular bupivacaine infusion for postoperative analgesia after anterior cruciate ligament reconstruction: a double-blinded, placebo-controlled, prospective, and randomized study. Am J Sports Med. 2007 Apr;35(4):531-6. doi: 10.1177/0363546506296313. Epub 2007 Jan 23.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças musculoesqueléticas
- Artrite
- Doenças articulares
- Doenças Reumáticas
- Osteoartrite
- Osteoartrite, Joelho
- Hormônios
- Hormônios, substitutos hormonais e antagonistas hormonais
- Produtos químicos orgânicos
- Compostos policíclicos
- Anilides
- Amidas
- Compostos de anilina
- Aminas
- Triamcinolona
- Pregada
- Pregnas
- Esteróides
- Compostos de anel fundido
- Esteróides, fluorados
- Bupivacaína
- Acetonido de triancinolona
- Hormônios do córtex adrenal
Outros números de identificação do estudo
- PI_ PAL_V3_ 8
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .